in absolute terms there appears to be a difference, but proportinally both about doubled the RR compared to placebo. even if absolute difference is mroe relevant, i woudl argue the 8% spread in a rather small study in a disease with a good deal of heterogeneity between subjects and an endpoint that relies on some subjective components (vs a "harder" endpoint) is meaningless
Market Data 
Markets 
AI
